James D. Dondero - 29 Apr 2024 Form 4 Insider Report for NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT)

Signature
/s/ James Dondero
Issuer symbol
NXDT
Transactions as of
29 Apr 2024
Net transactions value
$0
Form type
4
Filing time
30 Apr 2024, 17:31:49 UTC
Previous filing
15 Apr 2024
Next filing
09 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXDT Common Stock Award +65,398 +11% 672,417 29 Apr 2024 See Footnote F1, F2
transaction NXDT Common Stock Award +71,310 +11% 743,726 29 Apr 2024 See Footnote F2, F3
transaction NXDT Common Stock Award +71,410 +9.6% 815,136 29 Apr 2024 See Footnote F2, F4
holding NXDT Common Stock 1,904,136 29 Apr 2024 See Footnote F5
holding NXDT Common Stock 4,281,441 29 Apr 2024 Direct F6
holding NXDT Common Stock 105,309 29 Apr 2024 See Footnote F7
holding NXDT Common Stock 536,032 29 Apr 2024 See Footnote F6, F8
holding NXDT Common Stock 65,949 29 Apr 2024 By employee benefit plan F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Under the terms of the Advisory Agreement, dated July 1, 2022, by and between NexPoint Diversified Real Estate Trust (the "Company") and NexPoint Real Estate Advisers X, L.P. (the "Adviser"), as amended by that First Amendment to Advisory Agreement dated October 25, 2022, and as amended by that Second Amendment to Advisory Agreement, dated April 11, 2023 (the "Advisory Agreement"), the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the volume-weighted average price ("VWAP") of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 65,398.36 common shares to the Adviser as payment of its fees for the month of January at a VWAP of $6.8934 per share.
F2 32,082 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 71,171.75 shares are held by PCMG Trading Partners XXIII, L.P., 180,159 shares are held by Governance Re Ltd. and 523,786.35 shares (following the transactions described herein) are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F3 Under the terms of the Advisory Agreement, the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the VWAP of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 71,309.60 common shares to the Adviser as payment of its fees for the month of February at a VWAP of $6.4507 per share.
F4 Under the terms of the Advisory Agreement, the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the VWAP of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 71,409.78 common shares to the Adviser as payment of its fees for the month of March at a VWAP of $6.3131 per share.
F5 1,330,582 shares are held by Highland Opportunities and Income Fund and 573,554 shares are held by Highland Global Allocation Fund. These entities are managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management"), which is ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F6 Includes shares acquired under a dividend reinvestment plan.
F7 These shares are held by The Dugaboy Investment Trust of which Mr. Dondero is the beneficiary pursuant to an employee purchase plan. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F8 These shares are held by subsidiaries of The Dugaboy Investment Trust. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Remarks:

President